Clin Cancer Res 2012, 18:534–545 PubMedCrossRef 28 Panarelli NC,

Clin Cancer Res 2012, 18:534–545.PubMedCrossRef 28. Panarelli NC, Chen YT, Zhou XK, Kitabayashi N,

Yantiss RK: MicroRNA expression aids the preoperative diagnosis of learn more pancreatic ductal adenocarcinoma. Pancreas 2012, 41:685–690.PubMed 29. Ali S, Saleh H, Sethi S, Sarkar FH, Philip PA: MicroRNA profiling of diagnostic needle aspirates CH5424802 concentration from patients with pancreatic cancer. Br J Cancer 2012, 107:1354–1360.PubMedCrossRef 30. Zhang S, Hao J, Xie F, Hu X, Liu C, Tong J, Zhou J, Wu J, Shao C: Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development. Carcinogenesis 2011, 32:1183–1189.PubMedCrossRef 31. Nagao Y, Hisaoka M, Matsuyama A, Kanemitsu S, Hamada T, Fukuyama T, Nakano R, Uchiyama A, Kawamoto M, Yamaguchi K, Hashimoto H: Association of microRNA-21 this website expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma. Mod Pathol 2012, 25:112–121.PubMedCrossRef 32. Sato F, Tsuchiya S, Terasawa L, Tsujimoto G: Intra-platform repeatability and inter-platform comparability of microRNA microarray technology. Plos One 2009, 4:e5540.PubMedCrossRef 33. Wang B, Howel P, Bruheim S, Ju J, Owen LB, Fodstad O, Xi Y: Systematic evaluation of three microRNA profiling

platforms: microarray, breads array, and quantative real-time PCR array. Plos One 2011, 6:e17167.PubMedCrossRef 34. Git A, Dvinge H, Salmon-Divon M, Osborne M, Kutter C, Hadfield J, Bertone P, Caldas C: Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring

differential microRNA expression. RNA 2010, 16:991–1006.PubMedCrossRef 35. Etienne W, Meyer MH, Peppers J, Meyer RA Jr: Comparison of mRNA gene expression by RT-PCR and DNA microarray. Biotechniques 2004, 36:618–620.PubMed 36. Zhang XJ, Ye H, Zeng CW, He B, Zhang H, Chen 4��8C YQ: Dysregulation of miR-15a and miR-214 in human pancreatic cancer. J Hematol Oncol 2010, 3:46.PubMedCrossRef 37. Tavano F, di Mola FF, Piepoli A, Panza A, Copetti M, Burbaci FP, Latiano T, Pellegrini F, Maiello E, Andriulli A, di Sebastiano P: Changes in miR-143 and miR-21 expression and clinicopathological correlations in pancreatic cancers. Pancreas 2012, 41:1280–1284.PubMedCrossRef 38. Greither T, Grochola LF, Udelnow A, Lautenschlager C, Wurl P, Taubert H: Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer 2010, 126:73–80.PubMedCrossRef 39. Papaconstantinou IG, Manta A, Gazouli M, Lyberopoulou A, Lykou dis PM, Polymeneas G, Voros D: Expression of microRNAs in patients with pancreatic cancer and its prognostic significance. Pancreas 2013, 42:67–71.PubMedCrossRef 40.

Comments are closed.